PortfoliosLab logoPortfoliosLab logo
TSHA vs. OPEN
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

TSHA vs. OPEN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Taysha Gene Therapies, Inc. (TSHA) and Opendoor Technologies Inc. (OPEN). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

TSHA vs. OPEN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
TSHA
Taysha Gene Therapies, Inc.
-18.73%217.92%-2.26%-21.68%-80.60%-56.10%10.31%
OPEN
Opendoor Technologies Inc.
-19.73%276.52%-64.29%286.21%-92.06%-35.72%43.05%

Fundamentals

Market Cap

TSHA:

$1.43B

OPEN:

$3.59B

EPS

TSHA:

-$0.34

OPEN:

-$1.74

PS Ratio

TSHA:

148.04

OPEN:

0.80

PB Ratio

TSHA:

5.79

OPEN:

3.57

Total Revenue (TTM)

TSHA:

$9.77M

OPEN:

$4.37B

Gross Profit (TTM)

TSHA:

$6.30M

OPEN:

$350.00M

EBITDA (TTM)

TSHA:

-$108.26M

OPEN:

-$287.00M

Returns By Period

In the year-to-date period, TSHA achieves a -18.73% return, which is significantly higher than OPEN's -19.73% return.


TSHA

1D
9.83%
1M
-1.32%
YTD
-18.73%
6M
36.70%
1Y
221.58%
3Y*
77.63%
5Y*
-26.04%
10Y*

OPEN

1D
5.64%
1M
-13.65%
YTD
-19.73%
6M
-39.32%
1Y
374.12%
3Y*
40.06%
5Y*
-25.97%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TSHA vs. OPEN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TSHA
TSHA Risk / Return Rank: 9191
Overall Rank
TSHA Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
TSHA Sortino Ratio Rank: 9494
Sortino Ratio Rank
TSHA Omega Ratio Rank: 9090
Omega Ratio Rank
TSHA Calmar Ratio Rank: 9191
Calmar Ratio Rank
TSHA Martin Ratio Rank: 8787
Martin Ratio Rank

OPEN
OPEN Risk / Return Rank: 9292
Overall Rank
OPEN Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
OPEN Sortino Ratio Rank: 9595
Sortino Ratio Rank
OPEN Omega Ratio Rank: 9191
Omega Ratio Rank
OPEN Calmar Ratio Rank: 9595
Calmar Ratio Rank
OPEN Martin Ratio Rank: 8888
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TSHA vs. OPEN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Taysha Gene Therapies, Inc. (TSHA) and Opendoor Technologies Inc. (OPEN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TSHAOPENDifference

Sharpe ratio

Return per unit of total volatility

2.35

2.28

+0.07

Sortino ratio

Return per unit of downside risk

3.33

3.46

-0.13

Omega ratio

Gain probability vs. loss probability

1.40

1.40

0.00

Calmar ratio

Return relative to maximum drawdown

4.23

5.71

-1.48

Martin ratio

Return relative to average drawdown

9.01

9.41

-0.40

TSHA vs. OPEN - Sharpe Ratio Comparison

The current TSHA Sharpe Ratio is 2.35, which is comparable to the OPEN Sharpe Ratio of 2.28. The chart below compares the historical Sharpe Ratios of TSHA and OPEN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


TSHAOPENDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.35

2.28

+0.07

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.19

-0.23

+0.04

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.20

-0.12

-0.08

Correlation

The correlation between TSHA and OPEN is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

TSHA vs. OPEN - Dividend Comparison

Neither TSHA nor OPEN has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

TSHA vs. OPEN - Drawdown Comparison

The maximum TSHA drawdown since its inception was -98.14%, roughly equal to the maximum OPEN drawdown of -98.57%. Use the drawdown chart below to compare losses from any high point for TSHA and OPEN.


Loading graphics...

Drawdown Indicators


TSHAOPENDifference

Max Drawdown

Largest peak-to-trough decline

-98.14%

-98.57%

+0.43%

Max Drawdown (1Y)

Largest decline over 1 year

-31.13%

-57.47%

+26.34%

Max Drawdown (5Y)

Largest decline over 5 years

-97.76%

-97.93%

+0.17%

Current Drawdown

Current decline from peak

-85.92%

-86.52%

+0.60%

Average Drawdown

Average peak-to-trough decline

-76.71%

-74.23%

-2.48%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.60%

34.84%

-20.24%

Volatility

TSHA vs. OPEN - Volatility Comparison

Taysha Gene Therapies, Inc. (TSHA) and Opendoor Technologies Inc. (OPEN) have volatilities of 21.10% and 21.42%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


TSHAOPENDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.10%

21.42%

-0.32%

Volatility (6M)

Calculated over the trailing 6-month period

65.51%

64.21%

+1.30%

Volatility (1Y)

Calculated over the trailing 1-year period

99.28%

165.92%

-66.64%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

136.33%

113.89%

+22.44%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

131.85%

111.60%

+20.25%

Financials

TSHA vs. OPEN - Financials Comparison

This section allows you to compare key financial metrics between Taysha Gene Therapies, Inc. and Opendoor Technologies Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
5.49M
736.00M
(TSHA) Total Revenue
(OPEN) Total Revenue
Values in USD except per share items